Annexon has been granted a patent for compounds and salts for treating various disorders like neurodegenerative, inflammatory, autoimmune, ophthalmic, and metabolic diseases. The patent claim specifically mentions compounds represented by formula I or II. GlobalData’s report on Annexon gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Annexon Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Annexon, NSAID cancer drugs was a key innovation area identified from patents. Annexon's grant share as of January 2024 was 12%. Grant share is based on the ratio of number of grants to total number of patents.

A recently granted patent (Publication Number: US11814404B2) discloses a compound represented by formula I or II, with various specific embodiments outlined in the claims. The compound can have different substituents, such as hydroxyl, alkoxy, amino, halogen, nitro, cyano, and many others, providing a wide range of chemical variations. Additionally, the patent covers compounds where certain groups are combined to form specific cyclic structures, enhancing the potential applications of the compound in pharmaceutical compositions.

Furthermore, the patent includes claims related to pharmaceutical compositions containing the disclosed compound along with pharmaceutically acceptable excipients. This indicates the potential utility of the compound in the development of new drugs or therapeutic agents. The patent's detailed description of the compound's structural variations and permissible substitutions provides valuable insights for researchers and pharmaceutical companies looking to innovate in the field of drug discovery and development.

To know more about GlobalData’s detailed insights on Annexon, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies